Baidu
map

2018 ACS指南:抗栓药物围术期管理

2018-08-23 美国外科医师协会 J Am Coll Surg. 2018 Aug 23.

2018年8月,美国外科医师协会(ACS)发布了抗栓药物围术期管理指南,人口老龄化以及慢性疾病治疗的不断进展增加了普通外科手术的复杂因素,大约有1/10的接受普通外科手术的患者长期服用抗凝药物,本文主要针对这些患者在围术期的管理提出指导建议。

中文标题:

2018 ACS指南:抗栓药物围术期管理

英文标题:

American College of Surgeons'' Guidelines for the Perioperative Management of Antithrombotic Medication.

发布机构:

美国外科医师协会

发布日期:

2018-08-23

简要介绍:

2018年8月,美国外科医师协会(ACS)发布了抗栓药物围术期管理指南,人口老龄化以及慢性疾病治疗的不断进展增加了普通外科手术的复杂因素,大约有1/10的接受普通外科手术的患者长期服用抗凝药物,本文主要针对这些患者在围术期的管理提出指导建议。 

拓展指南:围术期相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 ACS指南:抗栓药物围术期管理)] GetToolGuiderByIdResponse(projectId=1, id=a13b91c00163325d, title=2018 ACS指南:抗栓药物围术期管理, enTitle=American College of Surgeons'' Guidelines for the Perioperative Management of Antithrombotic Medication., guiderFrom=J Am Coll Surg. 2018 Aug 23., authorId=null, author=, summary=2018年8月,美国外科医师协会(ACS)发布了抗栓药物围术期管理指南,人口老龄化以及慢性疾病治疗的不断进展增加了普通外科手术的复杂因素,大约有1/10的接受普通外科手术的患者长期服用抗凝药物,本文主要针对这些患者在围术期的管理提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=654, associationName=美国外科医师协会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Aug 23 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年8月,美国外科医师协会(ACS)发布了抗栓药物围术期管理指南,人口老龄化以及慢性疾病治疗的不断进展增加了普通外科手术的复杂因素,大约有1/10的接受普通外科手术的患者长期服用抗凝药物,本文主要针对这些患者在围术期的管理提出指导建议。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>围术期</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=54d121c001586efe" title="2018 APAGBI指南:儿童患者围术期静脉血栓栓塞的预防" target=_blank>2018 APAGBI指南:儿童患者围术期静脉血栓栓塞的预防</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=aa6af1c0015a54a1" title="胃内镜黏膜下剥离术围术期指南" target=_blank>胃内镜黏膜下剥离术围术期指南</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=a9f321c0015390d9" title="2018 ASA实践建议:围术期周围神经病的预防(更新版)" target=_blank>2018 ASA实践建议:围术期周围神经病的预防(更新版)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=df94e1c001538547" title="美国心律学会和美国麻醉医师学会关于心血管植入型电子器械患者围术期处理专家共识解读" target=_blank>美国心律学会和美国麻醉医师学会关于心血管植入型电子器械患者围术期处理专家共识解读</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=90e731c0015301c6" title="2017 共识声明:围术期肌松监测的应用" target=_blank>2017 共识声明:围术期肌松监测的应用</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E5%9B%B4%E6%9C%AF%E6%9C%9F" target=_blank>有关围术期更多指南</a></ul>, tagList=[TagDto(tagId=11568, tagName=抗栓药物), TagDto(tagId=54430, tagName=围术期管理)], categoryList=[CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12688, appHits=269, showAppHits=14, pcHits=7848, showPcHits=6277, likes=120, shares=10, comments=2, approvalStatus=1, publishedTime=Wed Aug 29 22:24:39 CST 2018, publishedTimeString=2018-08-23, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Aug 29 22:24:39 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 17:08:58 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ACS指南:抗栓药物围术期管理)])
2018 ACS指南:抗栓药物围术期管理
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=341708, encodeId=f10b341e08a4, content=学习了,谢谢作者分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Aug 30 06:59:35 CST 2018, time=2018-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341705, encodeId=3a15341e0523, content=学习了谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Thu Aug 30 06:53:03 CST 2018, time=2018-08-30, status=1, ipAttribution=)]
    2018-08-30 1e145228m78(暂无匿称)

    学习了,谢谢作者分享!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=341708, encodeId=f10b341e08a4, content=学习了,谢谢作者分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Aug 30 06:59:35 CST 2018, time=2018-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=341705, encodeId=3a15341e0523, content=学习了谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Thu Aug 30 06:53:03 CST 2018, time=2018-08-30, status=1, ipAttribution=)]
    2018-08-30 chinadoctorliu_19344479

    学习了谢谢

    0

Baidu
map
Baidu
map
Baidu
map